Skip to content
Trial Eligibility
Menu

Risk Factors for Sudden Unexplained Death in Epilepsy

NCT01662453

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a brief telephone interview about their loved one's epilepsy and seizure history and the circumstances of his or her death.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • SUDEP

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Accepted
Sponsor
NYU Langone Health
Last updated on ClinicalTrials.gov
June 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • NYU Comprehensive Epilepsy Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.